Literature DB >> 21296873

A unified view of cystic fibrosis transmembrane conductance regulator (CFTR) gating: combining the allosterism of a ligand-gated channel with the enzymatic activity of an ATP-binding cassette (ABC) transporter.

Kevin L Kirk1, Wei Wang.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a unique ion channel in that its gating is coupled to an intrinsic enzymatic activity (ATP hydrolysis). This enzymatic activity derives from the evolutionary origin of CFTR as an ATP-binding cassette transporter. CFTR gating is distinct from that of a typical ligand-gated channel because its ligand (ATP) is usually consumed during the gating cycle. However, recent findings indicate that CFTR gating exhibits allosteric properties that are common to conventional ligand-gated channels (e.g. unliganded openings and constitutive mutations). Here, we provide a unified view of CFTR gating that combines the allosterism of a ligand-gated channel with its unique enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21296873      PMCID: PMC3075628          DOI: 10.1074/jbc.R111.219634

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Two-state allosteric behavior in a single-domain signaling protein.

Authors:  B F Volkman; D Lipson; D E Wemmer; D Kern
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

2.  Allosteric activation mechanism of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine.

Authors:  Y Chang; D S Weiss
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

3.  A conditional probability analysis of cystic fibrosis transmembrane conductance regulator gating indicates that ATP has multiple effects during the gating cycle.

Authors:  D J Hennager; M Ikuma; T Hoshi; M J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

4.  Allosteric linkage between voltage and Ca(2+)-dependent activation of BK-type mslo1 K(+) channels.

Authors:  J Cui; R W Aldrich
Journal:  Biochemistry       Date:  2000-12-19       Impact factor: 3.162

5.  Linking the acetylcholine receptor-channel agonist-binding sites with the gate.

Authors:  David J Cadugan; Anthony Auerbach
Journal:  Biophys J       Date:  2010-08-04       Impact factor: 4.033

6.  Voltage-dependent flickery block of an open cystic fibrosis transmembrane conductance regulator (CFTR) channel pore.

Authors:  Z Zhou; S Hu; T C Hwang
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

7.  Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels.

Authors:  F Wang; S Zeltwanger; S Hu; T C Hwang
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

Review 8.  Structured disorder and conformational selection.

Authors:  C J Tsai; B Ma; Y Y Sham; S Kumar; R Nussinov
Journal:  Proteins       Date:  2001-09-01

9.  The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover.

Authors:  Luba Aleksandrov; Andrei A Aleksandrov; Xiu-Bao Chang; John R Riordan
Journal:  J Biol Chem       Date:  2002-02-22       Impact factor: 5.157

10.  The non-hydrolytic pathway of cystic fibrosis transmembrane conductance regulator ion channel gating.

Authors:  A A Aleksandrov; X Chang; L Aleksandrov; J R Riordan
Journal:  J Physiol       Date:  2000-10-15       Impact factor: 5.182

View more
  23 in total

Review 1.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

2.  Long-range coupling between the extracellular gates and the intracellular ATP binding domains of multidrug resistance protein pumps and cystic fibrosis transmembrane conductance regulator channels.

Authors:  Shipeng Wei; Bryan C Roessler; Mert Icyuz; Sylvain Chauvet; Binli Tao; John L Hartman; Kevin L Kirk
Journal:  FASEB J       Date:  2015-11-25       Impact factor: 5.191

Review 3.  Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis.

Authors:  Zhi-wei Cai; Jia Liu; Hong-yu Li; David N Sheppard
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

Review 4.  CFTR: folding, misfolding and correcting the ΔF508 conformational defect.

Authors:  Gergely L Lukacs; A S Verkman
Journal:  Trends Mol Med       Date:  2011-12-03       Impact factor: 11.951

5.  State-dependent blocker interactions with the CFTR chloride channel: implications for gating the pore.

Authors:  Paul Linsdell
Journal:  Pflugers Arch       Date:  2014-03-28       Impact factor: 3.657

6.  The silent codon change I507-ATC->ATT contributes to the severity of the ΔF508 CFTR channel dysfunction.

Authors:  Ahmed Lazrak; Lianwu Fu; Vedrana Bali; Rafal Bartoszewski; Andras Rab; Viktoria Havasi; Steve Keiles; John Kappes; Ranjit Kumar; Elliot Lefkowitz; Eric J Sorscher; Sadis Matalon; James F Collawn; Zsuzsanna Bebok
Journal:  FASEB J       Date:  2013-08-01       Impact factor: 5.191

7.  The CFTR ion channel: gating, regulation, and anion permeation.

Authors:  Tzyh-Chang Hwang; Kevin L Kirk
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

8.  A synonymous codon change alters the drug sensitivity of ΔF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Vedrana Bali; Ahmed Lazrak; Purushotham Guroji; Lianwu Fu; Sadis Matalon; Zsuzsanna Bebok
Journal:  FASEB J       Date:  2015-09-03       Impact factor: 5.191

9.  G551D mutation impairs PKA-dependent activation of CFTR channel that can be restored by novel GOF mutations.

Authors:  Wei Wang; Lianwu Fu; Zhiyong Liu; Hui Wen; Andras Rab; Jeong S Hong; Kevin L Kirk; Steven M Rowe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-02       Impact factor: 5.464

10.  ATP-driven Rad50 conformations regulate DNA tethering, end resection, and ATM checkpoint signaling.

Authors:  Rajashree A Deshpande; Gareth J Williams; Oliver Limbo; R Scott Williams; Jeff Kuhnlein; Ji-Hoon Lee; Scott Classen; Grant Guenther; Paul Russell; John A Tainer; Tanya T Paull
Journal:  EMBO J       Date:  2014-02-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.